[HTML][HTML] NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential

K Li, T Yao, Y Zhang, W Li, Z Wang - International journal of …, 2021 - ncbi.nlm.nih.gov
The nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA (lncRNA)
that is upregulated in a variety of human cancer types. Increasing evidence has shown that …

Long noncoding RNAs (lncRNAs) in pancreatic cancer progression

M Ashrafizadeh, N Rabiee, AP Kumar, G Sethi… - Drug Discovery …, 2022 - Elsevier
Long noncoding RNAs (lncRNAs) are RNA molecules involved in gene regulation at
transcriptional, post-transcriptional, and epigenetic levels. LncRNAs participate in regulating …

HGF/c-Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR/NGF axis

T Qin, Y Xiao, W Qian, X Wang, M Gong, Q Wang… - Cell Death & …, 2022 - nature.com
Perineural invasion (PNI) is a pathologic feature of pancreatic cancer and is associated with
poor outcomes, metastasis, and recurrence in pancreatic cancer patients. However, the …

Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors

M Posta, B Győrffy - Clinical and Translational Science, 2023 - Wiley Online Library
Pancreatic adenocarcinoma remains a leading cause of cancer‐related deaths. In order to
develop appropriate therapeutic and prognostic tools, a comprehensive mapping of the …

Pancreatic cancer and platelets crosstalk: a potential biomarker and target

S Mai, I Inkielewicz-Stepniak - Frontiers in cell and developmental …, 2021 - frontiersin.org
Platelets have been recognized as key players in hemostasis, thrombosis, and cancer.
Preclinical and clinical researches evidenced that tumorigenesis and metastasis can be …

Design, synthesis and in vitro investigation of cabozantinib-based PROTACs to target c-Met kinase

AA Sachkova, DV Andreeva, AS Tikhomirov… - Pharmaceutics, 2022 - mdpi.com
(1) Background: This investigation aimed at developing a series of c-Met-targeting
cabozantinib-based PROTACs.(2) Methods: Purification of intermediate and target …

CTHRC1 induces pancreatic stellate cells (PSCs) into myofibroblast-like cancer-associated fibroblasts (myCAFs)

MK Kang, F Jiang, YJ Kim, K Ryu, A Masamune… - Cancers, 2023 - mdpi.com
Simple Summary CTHRC1 is a protein with pro-tumoral effects that is highly expressed in
tumors. We found that cancer stroma is the major source of CTHRC1 secretion in pancreatic …

The role of molecular testing in pancreatic cancer

DB Zhen, RA Safyan, EQ Konick… - Therapeutic …, 2023 - journals.sagepub.com
Pancreatic ductal adenocarcinoma (PDA) is highly aggressive and has few treatment
options. To personalize therapy, it is critical to delineate molecular subtypes and understand …

Targeting the stroma in the management of pancreatic cancer

P Edwards, BW Kang, I Chau - Frontiers in Oncology, 2021 - frontiersin.org
Pancreatic cancer (PC) presents extremely aggressive tumours and is associated with poor
survival. This is attributed to the unique features of the tumour microenvironment (TME) …

Savolitinib: A promising targeting agent for cancer

TS Lee, JY Kim, MH Lee, IR Cho, WH Paik, JK Ryu… - Cancers, 2023 - mdpi.com
Simple Summary Savolitinib is a highly specific inhibitor of the MET tyrosine kinase. Both
preclinical and clinical studies have shown its potential as a treatment for various cancers …